Please complete the CAPTCHA to continue
@its.jnj.com
✓
2 phones found area 408
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Wei Wu, Phd is listed as Biotech Executive / Healthcare Investor at Johnson & Johnson, based in San Francisco Bay Area, United States, United States. AeroLeads shows a work email signal at its.jnj.com, phone signal with area code 408, and a matched LinkedIn profile for Wei Wu, Phd.
Wei Wu, Phd previously worked as Senior Director, Venture Investments, JJDC at Johnson & Johnson and Board Member at Circode Biomed. Wei Wu, Phd holds Postdoc, Pathology | Healthcare Business And Finance from Stanford University.
This section adds company-level context without repeating Wei Wu, Phd's masked contact details.
AeroLeads found 2 current-domain work email signals for Wei Wu, Phd. Compare company email patterns before reaching out.
Wei Wu, Phd is a Biotech Executive / Healthcare Investor at Johnson & Johnson. They possess expertise in molecular biology, genetics, cell culture, molecular cloning, cell biology and 15 more skills.
Listed skills include Molecular Biology, Genetics, Cell Culture, Molecular Cloning, and 16 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
New Brunswick, NJ, US
JJDC is the strategic corporate venture capital group for Johnson & Johnson; launched in 1973, it is one of the longest-running and most reputable CVC in health care. I cover investments in areas of strategic interest to Johnson & Johnson. In support of J&J strategic objectives, I work closely with Innovation Centers, JLabs, Therapeutic Areas, Business.
Circode develops novel RNA therapeutics for multiple disease areas
DAC Biotechnology is an antibody-drug-conjugate (ADC) company that has established an end-to-end capability for ADC generation and an innovative pipeline in pre-clinical and clinical stages.
West Hills, California, US
ImmPact Bio is pioneering a novel strategy to surmount a major challenge compromising current T-cell (CAR-T) therapy.Acquired by Lyell Immunopharma (LYEL) in 2024.
Berkeley, CA, US
Actym Therapeutics is developing a microbial-based immunotherapy platform for various challenging cancer types.
Illumina Ventures is an independently managed fund focused on early-stage companies that are pioneering new applications of genomics and enabling precision medicine. We invest in life science tools, therapeutics, clinical diagnostics, and other opportunities to improve human health.Covered investments: Actym Therapeutics, Kallyope, Encoded Therapeutics.
Immunotherapies for cancer
Beijing, CN
BOE Technology Group is a FORBES global2000 company headquartered in Beijing, China. -Lead all aspects of sourcing and deal execution in healthcare business-Manage collaboration projects, investment portfolio, and LP-GP relationship-Recruitment, training, and team building-Corporate strategy and business development-PR/marketing/ecosystem expansion
Sunnyvale, California, US
Ceribell is focused on making EEG widely accessible, drastically more efficient, and more cost-effective to improve the diagnosis and treatment of neurological patients.IPO in 2024
Durham, NC, US
Baebies, guided by the vision that “everyone deserves a healthy start,” delivers innovative products and services for newborn screening and pediatric testing.
Sunnyvale, CA, US
Life Science Angels is the premier angel investment group investing in medical devices, diagnostics, pharmaceuticals, biotechnology, genomics, and digital health. It's ranked as the top 1/350 angel investment groups in US by CB Insights in 2014. Typical investments range from $200-$600k, with syndicated financings ranging to $2-3M. - Lead a team of fellows.
Sunnyvale, CA, US
Männedorf, ZH, CH
NuGEN Technologies was acquired by TECAN to become TECAN Genomics. - Technical lead of cross-functional core team to research and develop a broad spectrum of Next-Generation-Sequencing based technologies and products- Collaborate on projects with research institutes and biopharmaceutical companies worldwide.
Palo Alto, CA, US
Department of Pathology and Developmental Biology, Stanford University/Howard Hughes Medical Institute:- Led 2 projects to understand the molecular mechanisms of developmental and induced neurogenesis for modeling human neurologic diseases and developing better therapeutic strategies. - Published 3 articles in high-profile scientific journals including.
- Initiated, coordinated and organized special focus issue "cell adhesion in axon growth"- Managed peer-review process and made expert recommendation to the editor-in-chief- Wrote editorial previews
Los Angeles, CA, US
Department of Biological Chemistry, David Geffen School of Medicine at UCLA/Howard Hughes Medical Institute:- Studied the structure and function of a homologue of human Down Syndrome Cell Adhesion Molecule in controling neural circuit assembly using Drosophila as the model system.- Published 4 original articles in top-tier scientific journals including.
Los Angeles, CA, US
- Evaluated invention disclosures from UCLA inventors, performed market research, and drafted non-confidential disclosures- Served as the liaison between UCLA inventors and industry, and worked with licensing team to commercialize inventions
Los Angeles, CA, US
- Molecular Biology, Life Science Core Curriculum for Undergraduates, 2008- Genetics, Life Science Core Curriculum for Undergraduates, 2007
- Studied the role of a MYB transcription factor in regulating circadian rythym of Arabidopsis.
Quick answers generated from the profile data available on this page.
Wei Wu, Phd works for Johnson & Johnson.
Wei Wu, Phd is listed as Biotech Executive / Healthcare Investor at Johnson & Johnson.
AeroLeads has found 2 work email signals at @its.jnj.com for Wei Wu, Phd at Johnson & Johnson.
AeroLeads has found 2 phone signal(s) with area code 408 for Wei Wu, Phd at Johnson & Johnson.
Wei Wu, Phd is based in San Francisco Bay Area, United States, United States while working with Johnson & Johnson.
Wei Wu, Phd has worked for Johnson & Johnson, Circode Biomed, Dac Biotech, Immpact Bio Usa Inc, and Actym Therapeutics, Inc..
You can use AeroLeads to view verified contact signals for Wei Wu, Phd at Johnson & Johnson, including work email, phone, and LinkedIn data when available.
Wei Wu, Phd holds Postdoc, Pathology | Healthcare Business And Finance from Stanford University.
Wei Wu, Phd is listed with skills including Molecular Biology, Genetics, Cell Culture, Molecular Cloning, Cell Biology, Biochemistry, Research, and Western Blotting.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts